Astellas Pharma EPS - Earnings per Share 2012-2024 | ALPMY
- Astellas Pharma EPS for the quarter ending December 31, 2024 was $0.00, a 100% decline year-over-year.
- Astellas Pharma 2025 annual EPS was $0.19, a 210% increase from 2024.
- Astellas Pharma 2024 annual EPS was $0.06, a 85.37% decline from 2023.
- Astellas Pharma 2023 annual EPS was $0.41, a 25.45% decline from 2022.
Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.